what you can use and what you cannot
CJC-1295 is an unapproved research peptide with large safety gaps.
This page explains what the research can tell you. It also marks the questions that need your own doctor, not a website.
The site explains research but cannot guide your care
CJC-1295 Safe helps you read the published CJC-1295 work in plain words. This page explains what you can and cannot get here.
No clinic or doctor runs this service. It gives no medical advice and sells nothing.
The useful part is simple: you can see what happened in each study. You can also see when an online claim goes past the facts.
Human blood tests were short. The long and short forms also stay in blood for very different times.
A mouse study found normal growth after one daily shot. A Phase 2 human program stopped after a reported death.
Public records don't prove the drug caused that death. There is still no long human safety test.
Higher insulin-like growth factor 1 has also been tied to some cancers in large groups [7]. That link does not prove the drug causes cancer.
Safe in the name is a question, not a promise
The word “safe” in the name isn't a claim about the drug. It means safety is the first question to ask.
CJC-1295 is an unapproved research drug. Confident online plans can't replace a controlled human test.
The human work only followed people for a short time. It can't tell you what long use might do.
Use these pages to understand the papers and their gaps. They cannot tell you whether the drug fits your health.
Square-bracket numbers let you check the published papers
A number inside square brackets points to the source for a test amount or percent change. The full paper list lets you check the original work.
Two drug books disagree about CJC-1295's exact formula, or list of parts. Neither version settles whether the drug is safe or useful.
When human proof stops, the claim must stop too. The pages do not turn a test amount into advice.
You can read the study findings, the growth hormone and insulin-like growth factor 1 steps, or the long and short forms. The short answers cover the main safety questions.
This site explains prescription access but does not supply CJC-1295 or give a treatment plan. Your own doctor must answer questions about your care.
Long human safety tests are still missing
The drug has no approval for use in people. No long human test has tracked harm over time.
One drug program stopped after a reported death. Public records don't prove that the drug caused the death.
Higher levels of the liver-made hormone have been tied to some cancers in large groups. That link does not prove the peptide causes cancer.
Growth hormone can also make the body hold salt and water. The FDA warned that the immune system might learn to fight the drug as foreign.
Sport bodies ban the drug as well. These facts matter more to you than any hoped-for claim about sleep, muscle, fat, or healing.
A fair account gives both parts of each study. You need to know what researchers found and what they never tested.